Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.87 Analyst target: $32.56 Upside: 454.68%
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The company is headquartered in Montreal, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.